Aakaar Medical Technologies IPO

About Aakaar Medical Technologies IPO

Aakaar Medical Technologies is an IPO of ₹27 crores. The IPO of Aakaar Medical Technologies Ltd consists only of a fresh issue of up to 37,50,400 equity shares of face value of ₹10 each. It has no offer for sale. The price band of the offer is ₹68 to ₹72. The lot size is 1600.

The opening date of the IPO is June 20, 2025 and the closing date of the IPO is June 24, 2025. The listing of shares will take place on June 27, 2025. The allotment date is June 25, 2025. The initiation of refunds will take place on June 26, 2025.

Objectives of Aakaar Medical Technologies IPO

• Funding working capital requirements of the company
• General corporate purposes

Industry Outlook

The global medical aesthetics and cosmetic dermatology market was valued at USD 35.9 Bn in CY2024 and is projected to reach USD 57.4 Bn by CY2030. It is expected to register a CAGR of 8.1% during CY2024 - CY2030. The Indian medical aesthetics and cosmetic dermatology market generated a revenue of USD 283.9 Mn in CY2024 and is expected to grow at a CAGR of 13.9% during the forecasted period to generate a revenue of USD 618.8 Mn in CY2030.

Company Information

Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics and specialised cosmetic products and devices. Its product range includes both its own brands and imported brands from countries such as Korea, Spain, Italy and Austria. The company supplies its products and devices primarily to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.

Risks of Aakaar Medical Technologies IPO

• Dependence on Imported Third-party Brands

A substantial portion of Aakaar’s revenue is derived from sale of imported third party manufactured brands which exposes it to various risks. Any disruption in these relationships, supply chain issues, or discontinuation of its alliance could adversely impact its ability to maintain a steady inventory and supply continuity, affecting customer satisfaction and revenue.

• Geographical Concentration

The company’s registered office is situated in Maharashtra and it derives a significant portion of its revenue from the state of Maharashtra and Karnataka, making it vulnerable to geographical concentration risk.

• Reliance on third party contract manufacturers

They rely on third party contract manufacturers (domestic and international) & loan licensing partnersfor manufacturing products & devices which they sell under their own Brand. Their dependence on third party manufacturers for the manufacturing of all their products subjects them to certain risks, which, if realized, could adversely affect their business, results of operations, cash flows and financial condition.

Peer Comparison

Aakaar Medical Technologies Ltd believes that with its pure play B2B business model supplying to Dermatologists/Aesthetic Physicians & concentration on Aesthetic Products only through doctors, there are no listed entities of similar size or similar business model in India, which is comparable with its business.

Anchor Investor Bidding Date The anchor investor bidding date is June 19, 2025.

• IPO Registrar: Bigshare Services Pvt Ltd
• Book Running Lead Manager: Indorient Financial Services Limited

Business Model

Aakaar’s product range includes both its own brands and imported brands.

• Sale of imported brands: The company sells products & devices of reputed aesthetic brands in India via distribution agreements/sourcing arrangements. This segment contributed 70% of the revenue for FY 2024.

• Sale of own brands: This business segment accounted for 30.22% of the company’s revenues in Financial Year 2024 & 39.57% of its revenues for five- month period ending August 31 2024.

Company Growth Trajectory

Aakaar’s revenue from operations jumped from ₹19.4653 crores in FY 22 to ₹46.1110 crores in FY 24. It further jumped to 61.5828 crores in FY 25. Its EBITDA jumped from ₹3.5286 crores in FY 22 to ₹4.9989 crores in FY 24 and 9.7369 crores in FY 25.

Market Position

Incorporated in 2013, Aakaar Medical Technologies has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company’s customer base was 5205 as of FY 24.

How to Check the Allotment Status of Aakaar Medical Technologies IPO?

1. Visit the Registrar’s Website

Visit the official website of Bigshare Services Pvt Ltd and choose ‘IPO Allotment Status’ from ‘Solutions’. Click on any one of the servers, choose the company name from the dropdown and input either your application number, beneficiary ID or PAN number. Enter captcha and click on ‘Search’ to know the allotment status.

2. Verify on the National Stock Exchange Website

The National Stock Exchange (NSE) has an IPO Bid Verification module. You can use it to check the status of Aakaar Medical Technologies Ltd IPO. Go to www.nseindia.com and find the 'Invest' tab. Click on 'Verify IPO Bids' under 'Resources & Tools'. On the NSE IPO Bid Verification page, enter:

• Company name from dropdown
• Application number
• PAN

Then click 'Submit' to know the allotment status.

How to Apply for Aakaar Medical Technologies IPO?

• Log in to your Kotak Securities Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
  
• Specify IPO details - Enter the number of lots and the price you wish to apply for.
  
• Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
  
• Mandate Notification - Your UPI app will receive a mandate notification to block funds.
  
• Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.